Discovery of CP-533536: an EP2 receptor selective prostaglandin E2 (PGE2) agonist that induces local bone formation.

Bioorg Med Chem Lett

Department of Cardiovascular and Metabolic Diseases, Pfizer Global Research and Development, Groton Laboratories, Eastern Point Road, Groton, CT 06340, USA.

Published: April 2009

Sulfonamides, exemplified by 3a, were identified as highly selective EP(2) agonists. Lead optimization led to the identification of CP-533536, 7f, a potent and selective EP(2) agonist. CP-533536 demonstrated the ability to heal fractures when administered locally as a single dose in rat models of fracture healing.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmcl.2009.01.059DOI Listing

Publication Analysis

Top Keywords

selective ep2
8
discovery cp-533536
4
cp-533536 ep2
4
ep2 receptor
4
receptor selective
4
selective prostaglandin
4
prostaglandin pge2
4
pge2 agonist
4
agonist induces
4
induces local
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!